Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

Dietary Antioxidant Intake and Risk of Type 2 Diabetes

  1. Jukka Montonen, MSC1,
  2. Paul Knekt, PHD12,
  3. Ritva Järvinen, PHD3 and
  4. Antti Reunanen, PHD1
  1. 1National Public Health Institute, Department of Health and Functional Capacity, Helsinki, Finland
  2. 2Social Insurance Institution, Helsinki and Turku, Finland
  3. 3Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
  1. Address correspondence and reprint requests to J. Montonen, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland. E-mail: jukka.montonen{at}ktl.fi
Diabetes Care 2004 Feb; 27(2): 362-366. https://doi.org/10.2337/diacare.27.2.362
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • Table 1—

    Age-, sex-, and energy-adjusted mean ± SD levels and percentages of baseline variables in cases of type 2 diabetes and noncases: the Finnish Mobile Clinic Health Examination Study, 1967–1972

    VariableCasesNoncasesP
    n3833,921
    Age (years)*53.7 ± 8.051.7 ± 7.6<0.001
    BMI (kg/m2)29.4 ± 4.526.2 ± 3.8<0.001
    Serum cholesterol (mmol/l)6.8 ± 1.37.0 ± 1.40.001
    Sex (men %)†47540.006
    Hypertension (%)2915<0.001
    Current smoker (%)28330.02
    Family history of diabetes (%)‡2719<0.001
    Child with birth weight >4,500 g (% women)16110.02
    Saturated fat (g/day)60.4 ± 27.960.2 ± 26.30.70
    Energy (kcal/day)§2,422 ± 8572,501 ± 5800.06
    Vitamin E (α-tocopherol equivalents mg/day)6.4 ± 2.17.2 ± 6.90.06
     α-Tocopherol (mg/day)5.6 ± 1.85.8 ± 2.00.06
     β-Tocopherol (mg/day)0.52 ± 0.220.54 ± 0.250.29
     γ-Tocopherol (mg/day)2.3 ± 3.12.5 ± 3.80.28
     δ-Tocopherol (mg/day)0.46 ± 0.960.51 ± 1.10.37
     α-Tocotrienol (mg/day)1.6 ± 0.711.6 ± 0.720.19
     β-Tocotrienol (mg/day)2.2 ± 0.732.2 ± 0.750.14
     γ-Tocotrienol (mg/day)0.10 ± 0.090.10 ± 0.100.34
     δ-Tocotrienol (mg/day)0.02 ± 0.040.02 ± 0.050.95
    Vitamin C (mg/day)71.7 ± 33.673.7 ± 36.40.32
    Total carotenoids (μg/day)‖3,466 ± 2,7733,713 ± 2,8800.10
     α-Carotene (μg/day)78.7 ± 14087.6 ± 1430.24
     β-Carotene (μg/day)1,695 ± 2,0321,849 ± 2,1080.17
     γ-Carotene (μg/day)39.7 ± 54.241.1 ± 47.90.58
     Lycopene (μg/day)703 ± 961735 ± 8680.48
     β-Cryptoxanthin (μg/day)2.7 ± 5.63.5 ± 5.60.01
     Lutein + zeaxanthin (μg/day)947 ± 341997 ± 3390.01
    • *

      ↵* Adjusted for sex and energy intake;

    • †

      ↵† adjusted for age and energy intake;

    • ‡

      ↵‡ proportion of persons having first-degree relatives with diabetes;

    • §

      ↵§ adjusted for age and sex;

    • ‖

      ↵‖ sum of six carotenoids.

  • Table 2—

    Adjusted* RR of type 2 diabetes between quartiles of energy-adjusted intake of antioxidants

    Quartile of intake
    P for trend
    1 Referent234
    Vitamin E (α-tocopherol equivalents mg/day)<5.515.51–6.266.27–7.31>7.31
     Cases/persons at risk128/1,07693/1,07682/1,07680/1,076
     RR (95% CI)10.79 (0.60–1.04)0.78 (0.58–1.06)0.69 (0.51–0.94)0.02
    α-Tocopherol (mg/day)<4.664.66–5.305.31–6.20>6.20
     Cases/persons at risk129/1,07689/1,07684/1,07681/1,076
     RR (95% CI)10.72 (0.54–0.96)0.80 (0.59–1.08)0.66 (0.49–0.90)0.02
    β-Tocopherol (mg/day)<0.380.38–0.490.50–0.64>0.64
     Cases/persons at risk110/1,07692/1,076106/1,07675/1,076
     RR (95% CI)10.97 (0.73–1.29)1.09 (0.82–1.43)0.76 (0.56–1.03)0.18
    γ-Tocopherol (mg/day)<0.790.79–1.231.24–2.06>2.06
     Cases/persons at risk111/1,07699/1,07680/1,07693/1,076
     RR (95% CI)10.91 (0.69–1.20)0.75 (0.56–1.01)0.77 (0.57–1.03)0.04
    δ-Tocopherol (mg/day)<0.090.09–0.150.16–0.28>0.28
     Cases/persons at risk113/1,07699/1,07686/1,07685/1,076
     RR (95% CI)10.85 (0.64–1.13)0.81 (0.60–1.08)0.69 (0.51–0.93)0.02
    α-Tocotrienol (mg/day)<1.071.07–1.541.55–2.05>2.05
     Cases/persons at risk111/1,076100/1,07688/1,07684/1,076
     RR (95% CI)10.95 (0.72–1.25)0.91 (0.68–1.21)0.91 (0.67–1.23)0.47
    β-Tocotrienol (mg/day)<1.691.69–2.152.16–2.67>2.67
     Cases/persons at risk110/1,076106/1,07686/1,07681/1,076
     RR (95% CI)10.97 (0.74–1.28)0.77 (0.58–1.03)0.76 (0.56–1.03)0.03
    γ-Tocotrienol (mg/day)<0.040.04–0.070.08–0.12>0.12
     Cases/persons at risk96/1,076107/1,07692/1,07688/1,076
     RR (95% CI)10.95 (0.72–1.26)0.88 (0.65–1.18)0.79 (0.59–1.07)0.11
    δ-Tocotrienol (mg/day)<0.0020.002–0.0060.007–0.01>0.01
     Cases/persons at risk105/1,076110/1,07676/1,07692/1,076
     RR (95% CI)11.01 (0.77–1.32)0.69 (0.51–0.93)0.84 (0.63–1.13)0.06
    Vitamin C (mg/day)<49.749.7–66.266.3–87.9>87.9
     Cases/persons at risk96/1,05796/1,06387/1,06198/1,068
     RR (95% CI)10.97 (0.73–1.29)0.91 (0.68–1.22)0.97 (0.72–1.32)0.77
    Total carotenoids (μg/day)†<1,8621,863–2,8652,867–4,519>4,519
     Cases/persons at risk112/1,06274/1,064110/1,06281/1,061
     RR (95% CI)10.71 (0.53–0.96)0.97 (0.74–1.27)0.71 (0.52–0.96)0.07
    α-Carotene (μg/day)<9.49.4–34.434.5–103>103
     Cases/persons at risk86/1,058102/1,06797/1,06292/1,062
     RR (95% CI)11.11 (0.83–1.49)1.02 (0.75–1.38)0.94 (0.69–1.28)0.55
    β-Carotene (μg/day)<698698–1,1041,105–2,121>2,121
     Cases/persons at risk100/1,06083/1,064114/1,06380/1,062
     RR (95% CI)10.83 (0.62–1.11)1.14 (0.87–1.51)0.74 (0.54–1.01)0.25
    γ-Carotene (μg/day)<6.36.4–28.528.6–60.3>60.3
     Cases/persons at risk109/1,05786/1,07093/1,06689/1,056
     RR (95% CI)10.78 (0.59–1.04)0.88 (0.67–1.18)0.82 (0.61–1.10)0.29
    Lycopene (μg/day)<112113–494495–1,064>1,064
     Cases/persons at risk110/1,05886/1,06893/1,06788/1,056
     RR (95% CI)10.79 (0.59–1.05)0.86 (0.65–1.14)0.81 (0.60–1.09)0.23
    β-Cryptoxanthin (μg/day)<0.240.24–1.361.37–4.18>4.18
     Cases/persons at risk134/1,05675/1,06280/1,06288/1,069
     RR (95% CI)10.54 (0.40–0.73)0.57 (0.43–0.76)0.58 (0.44–0.78)<0.001
    Lutein + zeaxanthin (μg/day)<749749–935936–1,156>1,156
     Cases/persons at risk112/1,05792/1,06496/1,06577/1,063
     RR (95% CI)10.91 (0.69–1.21)0.95 (0.71–1.26)0.74 (0.55–1.01)0.09
    • *

      ↵* Adjusted for age, sex, geographic area, occupation, smoking, BMI, and family history of diabetes, and energy intake;

    • †

      ↵† sum of six carotenoids.

PreviousNext
Back to top
Diabetes Care: 27 (2)

In this Issue

February 2004, 27(2)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dietary Antioxidant Intake and Risk of Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dietary Antioxidant Intake and Risk of Type 2 Diabetes
Jukka Montonen, Paul Knekt, Ritva Järvinen, Antti Reunanen
Diabetes Care Feb 2004, 27 (2) 362-366; DOI: 10.2337/diacare.27.2.362

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Dietary Antioxidant Intake and Risk of Type 2 Diabetes
Jukka Montonen, Paul Knekt, Ritva Järvinen, Antti Reunanen
Diabetes Care Feb 2004, 27 (2) 362-366; DOI: 10.2337/diacare.27.2.362
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
  • Disparities in Diabetes Care Between Smokers and Nonsmokers
  • Changing Patterns of Type 2 Diabetes Incidence Among Pima Indians
Show more Epidemiology/Health Services/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.